Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,101 public trials 617 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Active, Not Recruiting

Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

NCT04817241

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Yale University New Haven, Connecticut, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
View Trial Details
Active, Not Recruiting

Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

NCT05384587

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia - Chronic Phase, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • City of Hope Phoenix Scottsdale, Arizona, United States
  • USO Arizona Oncology Tucson, Arizona, United States
View all 80 locations
View Trial Details
Active, Not Recruiting

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

NCT04229979

Conditions
Acute Myeloid Leukemia, Disease Attributes, Disease Progression, +10 more
Locations
  • O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • UCLA Medical Hematology and Oncology Los Angeles, California, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Colorado Blood Cancer Institute - SCRI - PPDS Denver, Colorado, United States
View all 73 locations
View Trial Details
Active, Not Recruiting

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy

NCT05104775

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Malignancies, +11 more
Locations
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
  • Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details

Related conditions